Halley E. Gilbert - 01 Jun 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Director
Issuer symbol: PCVX
Report date: 01 Jun 2022
Net transaction value: $0
Form type: 4
Accepted by SEC: 03 Jun 2022, 16:29:42 UTC
Previous filing: 03 Mar 2022
Next filing: 17 Jun 2022
SEC filing: View on sec.gov
Reporting owner signature: Halley Gilbert, by /s/ Ron A. Metzger, Attorney-in-Fact

Key filing fact

Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 03 Jun 2022.

Key facts

This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2022, 16:29.

Change

Previous filing in this sequence was filed on 03 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Award

Transaction value: $0
Shares: +3,125
Change %
Price: $0.000000
Shares after: 3,125
Date: 01 Jun 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCVX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +18,750
Change %
Price: $0.000000
Shares after: 18,750
Date: 01 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,750
Exercise price: $22.70
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Footnote F2

The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.